Compare Davita Inc (DVA) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Williams Companies Inc — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while Williams Companies Inc trades at $72.66 (market cap $87.88B). The key difference: Williams Companies Inc is far larger — about 7.5× Davita Inc's market cap, and Williams Companies Inc pays a 2.92% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | WMB | |
|---|---|---|
Market Cap | $11.72B | $87.88B |
Sector | Health | Energy |
52-Week High | $240.96 | $79.40 |
52-Week Low | $103.87 | $56.51 |
Enterprise Value | $24.44B | $118.51B |
Dividend Yield | — | 2.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
WMB trades at $70.4, down 1.9% on the day, amid a bearish technical signal. The company reported mixed Q2 2026 earnings, missing EPS estimates but raising full-year EBITDA guidance to $8.4 billion. Strong profitability is evident with a 25.18% net income margin and 24.02% ROE, though valuation ratios like P/E of 28.05 appear elevated. The recent $5.5 billion acquisition of Momentum Midstream aims to bolster growth in the Haynesville region.
Outlook remains positive with analyst consensus strongly bullish (79% buy ratings) and a $87.14 price target, implying significant upside. Risks include execution of the Momentum integration, volatile energy prices, and high debt levels. Cash flow stability from fee-based contracts supports the dividend, but net cash flow turned negative in 2026 forecasts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
